New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
06:06 EDTUNHUnitedHealth upgraded to Conviction Buy from Neutral at Goldman
Goldman upgraded UnitedHealth based on valuation and less earnings exposure from health reforms. Price target is $68.
News For UNH From The Last 14 Days
Check below for free stories on UNH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
08:48 EDTUNHUnitedHealth weakness creates buying opportunity, says BMO Capital
BMO Capital expects UnitedHealth's increased specialty drug costs to be largely offset by favorable prior-period development and muted cost growth from other trend components . The firm thinks that the company's membership growth will be boosted by several catalysts for the rest of the year, and it keeps an Outperform rating on the stock.
April 17, 2014
12:53 EDTUNHOn The Fly: Midday Wrap
Subscribe for More Information
10:56 EDTUNHUnitedHealth backs FY14 EPS, revenue guidance
UnitedHealth earlier backed its FY14 EPS view of $5.40-$5.60, consensus $5.59, and its FY14 revenue view of $128B-$129B, consensus $128.94B.
10:51 EDTUNHHealth insurers slide after UnitedHealth results, cautious comments
Shares of a number of health insurers are falling after the largest company in the sector, UnitedHealth (UNH), reported slightly higher than expected first quarter profit but lower than expected revenue. WHAT'S NEW: UnitedHealth's first quarter earnings per share came in at $1.10, versus the consensus outlook of $1.09. The insurer reported revenue of $31.71B, compared with the consensus outlook of $31.99B. Taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on UnitedHealth's earnings, the company stated. Also pushing down the company's earnings was "a very expensive," new Hepatitis C therapy, UnitedHealth stated on its earnings conference call. Hepatitis C treatments cost UnitedHealth hundreds of millions of dollars in the first quarter, the company stated, though it also noted that demand for the treatments should drop going forward as initial pent-up demand for them starts to decline. The company indicated that it was looking to be reimbursed by states for the money it is spending on hepatitis vaccines for Medicaid patients. Meanwhile, UnitedHealth reiterated its fiscal 2014 EPS guidance of $5.40-$5.60 and its fiscal 2014 revenue guidance of $128B-$129B. PRICE ACTION: In mid-morning trading, UnitedHealth sank 3.7% to $75.31. Other health insurers also declined, with WellPoint (WLP) dropping 4% to $91.89, Aetna (AET) falling 3.3% to $67.54, Humana (HUM) declining 2.25% to $106.35, and Health Net (HNT) sliding 1% to $31.74.
06:02 EDTUNHUnitedHealth:Q1 negatively impacted by ACA taxes, ACA provisions, sequestration
Subscribe for More Information
06:02 EDTUNHUnitedHealth reports Q1 Medical Care Ratio 82.5%
Reports Q1 Optum revenue $11.2B
06:01 EDTUNHUnitedHealth reports Q1 EPS $1.10, consensus $1.09
Subscribe for More Information
April 16, 2014
15:17 EDTUNHNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
10:08 EDTUNHUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
10:00 EDTUNHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTUNHUnitedHealth April volatility elevated at 48 into Q1 and outlook
UnitedHealth April call option implied volatility is at 48, June is at 22, September is at 21; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on April 17.
05:39 EDTUNHUnitedHealth downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
April 15, 2014
06:32 EDTUNHPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use